|Date & Time||7-8 June 2022|
The National Center for Advancing Translational Sciences (NCATS) Assay Guidance Manual (AGM) program is hosting a two-day workshop that will cover a broad range of critical concepts, including practical approaches and best practices, for developing standardized 3D cellular assays with the hope of helping the community to successfully develop therapeutics for future pandemic threats. This workshop is jointly organized by NCATS, the National Institute of Allergy and Infectious Diseases (NIAID) and the Bill & Melinda Gates Foundation. The overall goal of this workshop is to help scientists establish robust, reproducible, scalable, consistent, advanced 3D tissue models to study pandemic threat viruses.
Session I: 3D Tissue Models: Utility & Limitations
Chair: Marc Ferrer (NCATS, NIH); Speakers: Christine Mummery (Leiden University Medical Center), Hans Clevers (F. Hoffman-La Roche Ltd), Linda Griffith (MIT), Anthony Atala (Wake Forest School of Medicine), Zhengpeng (Jason) Wan (MIT) & Jeffrey T. Borenstein (Draper)
Session II: Utility of the Existing 3D Tissue Models for Antiviral Drug Development
Chair: Ann E. Eakin (NIAID, NIH); Speakers: Donald E. Ingber (Wyss Institute at Harvard University), Lee Gehrke (MIT & Harvard Medical School), Sashi Ramani (Baylor College of Medicine), Sara Cherry (University of Pennsylvania) , Emily M. Lee (NCATS, NIH), Calvin Kuo (Stanford) & Jia Zhu (Fred Hutchinson Cancer Research Center)
Session III: Use of Robust & Reproducible 3D Tissue Models from Drug Discovery through Development
Chair: Robert Jordan (Bill & Melinda Gates Foundation); Speakers: Nicole C. Kleinstreuer (NIEHS, NIH) & Evi Struble (FDA)
Session IV: Summary of Discussions & Perspectives on the Challenges Ahead
Speakers: Simon Funnell (UK Health Security Agency)
See the agenda below and download it here.